Reference: GILA/ID/XBD-098/AFRICAAG
Board seat: Independent Director, Non-Executive
Primary board location: Mumbai with East African subsidiary meetings
Meeting model: Five parent boards, quarterly country-risk and annual field visit
Mandate type: International and Cross-Border Board Mandates
Status: Confidential live-search specification; client identity released only after conflict clearance and NDA.
The anonymised enterprise
A listed Indian crop-nutrition and biologicals producer is expanding manufacturing, distribution and demonstration farms through subsidiaries in East Africa.
Africa revenue is USD 120–180 million across multiple currencies. Products, registrations, government tenders, local distributors and seasonal credit create country and conduct exposure.
The board problem and strategic reason for appointment
The director must govern market entry without treating Africa as one risk category. Licence ownership, distributor beneficial ownership, foreign exchange, tender conduct, product claims and repatriation differ by jurisdiction.
The board is not buying a credential. It is appointing an independent decision-maker who can convert this problem into a governed sequence of choices, evidence and accountability. Success will be judged by the quality of decisions and control improvement, not by the number of recommendations made.
Board position, authority and interfaces
Parent Risk/Audit member with oversight of African subsidiaries; local-board appointment only where duties and insurance are clear.
The appointee will have direct, unfiltered access to the Company Secretary and to the relevant control-function leaders. Any advisory support requested by the board must remain management-executed: the director sets questions, tolerances and evidence standards, but does not become an executive or consultant.
First 12–18 month strategic charter
- Build country-by-country licence, beneficial-owner, sanctions and distributor map; review product registration, field claims, quality and stewardship; govern government tenders, agents, gifts and payment terms; stress currency, trapped cash, credit, inventory and repatriation with entry/exit triggers
- Make legal-entity governance real across jurisdictions: reserved matters, delegated authority, tax and transfer pricing, sanctions/export controls, data movement, permanent-establishment risk and local director duties must align.
- Create a country-risk and market-entry dashboard that distinguishes commercial underperformance from regulatory, partner, currency and geopolitical exposure, with exit or pause triggers agreed in advance.
Decision profile sought
Essential evidence
- Africa country executive, agri-input leader, compliance, finance or risk director; multi-jurisdiction and distributor judgement
Differentiators
- East African regulatory/tender experience, sanctions or currency crisis leadership; product stewardship
GILA will assess cross-cultural board judgement, first-hand multi-jurisdiction operations, independence from distribution or advisory interests, and willingness to protect the local entity when group pressure points elsewhere. Candidates should expect a case discussion based on an ambiguous board decision from this mandate, not a career-history interview alone.
Independence, suitability and downside diligence
The search will apply Section 149(6), Sections 164–165, Schedule IV and the applicable listing or sector rules to the entity’s legally verified status at the appointment date. Databank/proficiency status, listed-entity directorship and committee ceilings, pecuniary relationships, relatives’ interests, recent audit/advisory work and interlocking directorships will be checked. The appointment is subject to formal legal and secretarial confirmation; this posting is not a substitute for that determination.
Mandate-specific screens: Distributor, government, agent, NGO, bank or competitor interests; commission-based market-entry work; political exposure not fully disclosed.
Before accepting the seat, the candidate will receive under NDA the latest board composition, committee charters, material litigation/regulatory schedule, related-party map, last audited accounts, current D&O policy and the specific risk papers necessary to make an informed liability assessment.
Twelve-month outcomes
The board expects coherent group and entity governance, controlled cross-border growth and a board record that respects the duties and risks of every relevant jurisdiction. For this particular seat, the evidence will be:
- Country risks and beneficial owners verified; tender/distributor decisions meet conduct protocol; cash, licence and product exposure stay within entry/exit thresholds
Commitment, protection and economics
- Expected load: 24–30 days annually with field travel.
- Terms: Five-year parent term/local terms separately advised; cash fee; sanctions, product and international D&O cover.
- Protection: Appointment letter, deed of indemnity where legally available, appropriate D&O cover including discovery/run-off terms, access to independent advice under the board-approved protocol, and complete minuting of dissent.
- Equity: No stock options where the appointment is legally an independent-director seat subject to Section 149(9). Any private-company structure outside that perimeter will be expressly classified and separately advised; no equity is implied by this posting.
Search process
Conflict pre-clearance → GILA/SYMPHONY™ board-fit interview → mandate case → document-led diligence under NDA → references from board peers and control functions → NRC/owner interviews → statutory, regulatory and reputation checks → board recommendation. Candidate consent, disclosures and appointment approvals will follow the law and the entity’s constitutional documents.